IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA TechnologyPhase 1 trial aims to build on response seen in proof-of-concept trialCAMBRIDGE, MA and NEW YORK, NY / ACCESSWIRE / January 27, 2022 / IAVI, the nonprofit scientific research organization, and biotechnology company Moderna an...
Source: pharmiweb.com